skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sirt2 suppresses glioma cell growth through targeting NF-κB–miR-21 axis

Journal Article · · Biochemical and Biophysical Research Communications
;  [1]; ;  [2];  [3];  [1]
  1. Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai (China)
  2. Department of Laboratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai (China)
  3. Department of Rheumatology, Changzheng Hospital, Second Military Medical University, Shanghai (China)

Highlights: •Sirt2 expression is down-regulated in human glioma tissues and cell lines. •Sirt2 regresses glioma cell growth and colony formation via inducing apoptosis. •miR-21 is essential for the functions of Sirt2 in glioma cells. •Sirt2 deacetylates p65 to decrease miR-21 expression. -- Abstract: Sirtuins are NAD{sup +}-dependent deacetylases that regulate numerous cellular processes including aging, DNA repair, cell cycle, metabolism, and survival under stress conditions. The roles of sirtuin family members are widely studied in carcinogenesis. However, their roles in glioma remain unclear. Here we report that Sir2 was under expressed in human glioma tissues and cell lines. We found that Sirt2 overexpression decreased cell proliferation and colony formation capacity. In addition, Sirt2 overexpression induced cellular apoptosis via up-regulating cleaved caspase 3 and Bax, and down-regulating anti-apoptotic protein Bcl-2. Sirt2 knockdown obtained opposing results. We showed that Sirt2 overexpression inhibited miR-21 expression, and Sirt2 was not sufficient to reduce cell proliferation and colony formation as well as to induce apoptosis when miR-21 was knocked down in glioma cells. Mechanically, we demonstrated that Sirt2 deacetylated p65 at K310 and blocked p65 binding to the promoter region of miR-21, thus regressing the transcription of miR-21. In summary, Sirt2 is critical in human glioma via NF-κB–miR-21 pathway and Sirt2 activator may serve as candidate drug for glioma therapy.

OSTI ID:
22242198
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 441, Issue 3; Other Information: Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Sirt2 suppresses inflammatory responses in collagen-induced arthritis
Journal Article · Fri Nov 29 00:00:00 EST 2013 · Biochemical and Biophysical Research Communications · OSTI ID:22242198

The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma
Journal Article · Fri Mar 28 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22242198

The RNA-binding protein PCBP2 facilitates gastric carcinoma growth by targeting miR-34a
Journal Article · Fri Jun 13 00:00:00 EDT 2014 · Biochemical and Biophysical Research Communications · OSTI ID:22242198